Chemoinformaics analysis of 15-nor-Prezizaan-7-one
Molecular Weight | 190.286 | nRot | 0 |
Heavy Atom Molecular Weight | 172.142 | nRig | 15 |
Exact Molecular Weight | 190.136 | nRing | 3 |
Solubility: LogS | -3.96 | nHRing | 0 |
Solubility: LogP | 2.604 | No. of Aliphatic Rings | 3 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 3 |
Atoms Count | 32 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 14 | No. of Aromatic Carbocycles | 0 |
nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 2 | No. Saturated Carbocycles | 3 |
No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 13 | No. of Saturated Rings | 3 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 34.5143 |
nHD | 0 | BPOL | 18.9257 |
QED | 0.537 |
Synth | 5.548 |
Natural Product Likeliness | 3.167 |
NR-PPAR-gamma | 0.358 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0.007 |
Pgp-sub | 0 |
HIA | 0.003 |
CACO-2 | -4.637 |
MDCK | 0.000042 |
BBB | 0.606 |
PPB | 0.899534 |
VDSS | 0.842 |
FU | 0.0600105 |
CYP1A2-inh | 0.517 |
CYP1A2-sub | 0.508 |
CYP2c19-inh | 0.257 |
CYP2c19-sub | 0.791 |
CYP2c9-inh | 0.16 |
CYP2c9-sub | 0.209 |
CYP2d6-inh | 0.069 |
CYP2d6-sub | 0.819 |
CYP3a4-inh | 0.33 |
CYP3a4-sub | 0.26 |
CL | 8.787 |
T12 | 0.151 |
hERG | 0.013 |
Ames | 0.05 |
ROA | 0.29 |
SkinSen | 0.409 |
Carcinogencity | 0.423 |
EI | 0.374 |
Respiratory | 0.976 |
NR-Aromatase | 0.271 |
Antiviral | Yes |
Prediction | 0.586434 |